Gene · 9619
Papers3,998
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,998
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative Analysis of Differential Cellular Transcriptome and Proteome Regulation by HIV-1 and HIV-2 Pseudovirions in the Early Phase of Infection. | Int J Mol Sci | 2023 | 38203551 | PubTator, text mining | PubMed |
| Enhancing Immunotherapy in Ovarian Cancer: The Emerging Role of Metformin and Statins. | Int J Mol Sci | 2023 | 38203494 | PubTator, text mining | PubMed |
| Soluble CD83 modulates human-monocyte-derived macrophages toward alternative phenotype, function, and metabolism. | Front Immunol | 2023 | 38162675 | PubTator, text mining | PubMed |
| IGFBPL1 inhibits macrophage lipid accumulation by enhancing the activation of IGR1R/LXRα/ABCG1 pathway. | Aging (Albany NY) | 2023 | 38157252 | PubTator, text mining | PubMed |
| Cholesterol Metabolism in Antigen-Presenting Cells and HIV-1 Trans-Infection of CD4+ T Cells. | Viruses | 2023 | 38140588 | PubTator, text mining | PubMed |
| Cardiac PET Imaging of ATP Binding Cassette (ABC) Transporters: Opportunities and Challenges. | Pharmaceuticals (Basel) | 2023 | 38139840 | PubTator, text mining | PubMed |
| MP Allosterically Activates AMPK to Enhance ABCA1 Stability by Retarding the Calpain-Mediated Degradation Pathway. | Int J Mol Sci | 2023 | 38139111 | PubTator, text mining | PubMed |
| Cells in Atherosclerosis: Focus on Cellular Senescence from Basic Science to Clinical Practice. | Int J Mol Sci | 2023 | 38138958 | PubTator, text mining | PubMed |
| Epigenetic Profiling of Type 2 Diabetes Mellitus: An Epigenome-Wide Association Study of DNA Methylation in the Korean Genome and Epidemiology Study. | Genes (Basel) | 2023 | 38137029 | PubTator, text mining | PubMed |
| Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders. | Biomolecules | 2023 | 38136568 | PubTator, text mining | PubMed |
| Transgenerational Epigenetic DNA Methylation Editing and Human Disease. | Biomolecules | 2023 | 38136557 | PubTator, text mining | PubMed |
| Oxidative Stress Induced by Lipotoxicity and Renal Hypoxia in Diabetic Kidney Disease and Possible Therapeutic Interventions: Targeting the Lipid Metabolism and Hypoxia. | Antioxidants (Basel) | 2023 | 38136203 | PubTator, text mining | PubMed |
| Exosomes: New Insights into the Pathogenesis of Metabolic Syndrome. | Biology (Basel) | 2023 | 38132306 | PubTator, text mining | PubMed |
| A decreased level of high-density lipoprotein is a possible risk factor for type 2 diabetes mellitus: A review. | Health Sci Rep | 2023 | 38125279 | PubTator, text mining | PubMed |
| p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells. | Cell Death Dis | 2023 | 38123597 | PubTator, text mining | PubMed |
| TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer. | Cell Death Dis | 2023 | 38123542 | PubTator, text mining | PubMed |
| Methotrexate and cardiovascular prevention: an appraisal of the current evidence. | Ther Adv Cardiovasc Dis | 2023 | 38115784 | PubTator, text mining | PubMed |
| Identifying the natural products in the treatment of atherosclerosis by increasing HDL-C level based on bioinformatics analysis, molecular docking, and in vitro experiment. | J Transl Med | 2023 | 38115108 | PubTator, text mining | PubMed |
| Lipid compartments and lipid metabolism as therapeutic targets against coronavirus. | Front Immunol | 2023 | 38106410 | PubTator, text mining | PubMed |
| Association of serum Asprosin concentrations with heart failure. | BMC Cardiovasc Disord | 2023 | 38097977 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9619/papers?page=13